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Abstract 
Background: Deamination of adenine can occur spontaneously under physiological conditions generating the 
highly mutagenic lesion, hypoxanthine. This process is enhanced by ROS from exposure of DNA to ionizing radia‑
tion, UV light, nitrous acid, or heat. Hypoxanthine in DNA can pair with cytosine which results in A:T to G:C transition 
mutations after DNA replication. In Escherichia coli, deoxyinosine (hypoxanthine deoxyribonucleotide, dI) is removed 
through an alternative excision repair pathway initiated by endonuclease V. However, the correction of dI in mamma‑
lian cells appears more complex and was not fully understood.
Results: All four possible dI‑containing heteroduplex DNAs, including A‑I, C‑I, G‑I, and T‑I were introduced to repair 
reactions containing extracts from human cells. The repair reaction requires magnesium, dNTPs, and ATP as cofac‑
tors. We found G‑I was the best substrate followed by T‑I, A‑I and C‑I, respectively. Moreover, judging from the repair 
requirements and sensitivity to specific polymerase inhibitors, there were overlapping repair activities in processing 
of dI in DNA. Indeed, a hereditable non‑polyposis colorectal cancer cell line (HCT116) demonstrated lower dI repair 
activity that was partially attributed to lack of mismatch repair.
Conclusions: A plasmid‑based convenient and non‑radioisotopic method was created to study dI repair in human 
cells. Mutagenic dI lesions processed in vitro can be scored by restriction enzyme cleavage to evaluate the repair. 
The repair assay described in this study provides a good platform for further investigation of human repair pathways 
involved in dI processing and their biological significance in mutation prevention.
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Background
Deoxyinosine (hypoxanthine deoxyribonucleotide, dI) in 
DNA can arise from spontaneous deamination of deoxy-
adenosine residue, and is also induced by ROS produced 
from normal aerobic respiration. In addition, exposure 
of DNA to ionizing radiation, UV light, nitrous acid, or 
heat can promote the formation of dI [1, 2]. Alternatively, 
dI can be introduced by misincorporation of dITP in the 
nucleotide pool during replication [3, 4]. Deoxyinosine 
derived from deamination of deoxyadenosine in DNA is 
potentially mutagenic since it prefers to pair with dCTP 
during replication, yielding A:T to G:C transition muta-
tions at sites of adenine deamination [5].
In mammalian cells, base excision repair (BER) was 
thought to be the major pathway for dI repair. The exci-
sion of base damage is initiated by a specific DNA gly-
cosylase: Hypoxanthine is bound and excised efficiently 
by human N-methylpurine-DNA glycosylase (MPG, also 
known as AAG, ANPG, APNG, or MDG) [6]. From radi-
onucleotide incorporation fine mapping, the resulting 
apurinic/apyrimidinic (AP) sites are further processed by 
both the short patch pathway (1-nucleotide gap filling) 
with DNA polymerase (Pol) β and the long patch pathway 
(2-6 nucleotide resynthesis) with Pol δ and PCNA [7].
In Escherichia coli, early studies indicated that the DNA 
glycosylase encoded by alkA gene could recognize and 
release hypoxanthine residues from DNA [1]. However, 
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subsequent in vivo and in vitro studies showed that DNA 
glycosylase initiated BER is not the major pathway to 
process dI in E. coli [8, 9]. The repair pathway initiated 
by endonuclease V (EndoV, encoded by nfi gene [10]) was 
shown to be the major pathway for dI processing both 
in  vivo and in  vitro [8, 9, 11]. A mutagenesis assay also 
showed that under HNO2 treatment, which will promote 
hypoxanthine formation, that a nfi mutant demonstrated 
over a 200-fold increase in mutation frequency, while the 
alkA mutant did not significantly increase the mutation 
frequency under the same experimental conditions [12].
Endonuclease V (EndoV) in E. coli is active upon DNA 
exposed to UV light, OsO4, acids, or X-rays [10]. This 
enzyme was later characterized as 3′-deoxyinosine endo-
nuclease that incises the DNA at the second phospho-
diester bond 3′ to the dI lesion, leaving 3′-OH and 5′-P 
termini [13]. Nfi homologues from Thermotoga maritima 
possess 3′-exonuclease activity that might be used for 
removal of damaged bases [14], but similar exonucle-
ase activities were not found in EndoV from E. coli and 
mammalian cells. Therefore, additional enzymes are 
required to excise the dI lesions in the EndoV-mediated 
repair process. In our previous study, we found DNA pol 
I played dual roles in both repair synthesis and using its 
3′-5′ proofreading exonuclease to remove EndoV incised 
dI lesion [9, 11].
A mammalian homologue of E. coli nfi gene was identi-
fied and characterized [15]. The mouse EndoV seems to 
be active only on dI, while bacterial EndoV exhibits broad 
substrate spectrum. Furthermore, expression of mouse 
EndoV in an alkA, and nfi double mutant E. coli strain 
significantly suppresses the spontaneous mutagenesis 
frequency, which suggested that this eukaryotic EndoV 
initiates an alternative excision repair pathway for dI cor-
rection [15]. A biochemical analysis of purified human 
EndoV showed it favored dI-containing DNA but with 
only a minor preference on deoxyxanthosine-containing 
DNA [16]. Expression of hEndoV in E. coli cells deficient 
in nfi, mug and ung genes caused 3-fold reduction in 
mutation frequency [16]. However, recent reports dem-
onstrated efficient cleavage of inosine-containing RNA by 
human EndoV [17] suggesting that hEndoV may involve 
in RNA editing [18]. Therefore, the full involvement of 
hEndoV in dI repair in human cells is still unknown.
The major function of mismatch repair (MMR) is its 
role in correction of nucleotide base misincorporation 
during replication [19–21], which requires that repair be 
directed to a newly synthesized DNA strand. A strand-
specific nick or gap is sufficient to direct MMR in extracts 
of mammalian cell extracts, and an obvious possibility 
is that DNA termini that occur naturally at the replica-
tion fork serve as the strand signals that direct the reac-
tion in the eukaryotic cell [19]. Several purified systems 
have been reconstituted using near homogeneous human 
proteins and support 3′- and/or 5′-directed mismatch-
provoked excision or repair. According to the current 
model, the mismatch recognition activities MutS-α 
(MSH2·MSH6 heterodimer) or MutS-β (MSH2·MSH3 
heterodimer), MutL-α (MLH1·PMS2 heterodimer), RPA 
(replication protein A), the 5′–3′ double-strand hydro-
lytic activity exonuclease 1 (Exo1) [19], the replication 
clamp proliferating cell nuclear antigen (PCNA) and the 
clamp loader replication factor C (RFC) yields a system 
that supports mismatch-provoked excision directed by a 
3′ or 5′ strand break, and where hydrolysis is attenuated 
upon mismatch removal [19].
The roles and sequence events utilizing each of the 
aforementioned proteins have at least been partially elu-
cidated. RPA plays a primary role in terminating excision 
by MutS-α-activated Exo1; additionally high mobility 
group protein B1 (HMGB1) was found to substitute for 
RPA [19]. MutL-α is a latent endonuclease that is acti-
vated in a manner that depends on a mismatch, MutS-α, 
RFC, PCNA, ATP and a strand break. While the func-
tion of RFC in MutL-α activation is apparently restricted 
to clamp loading, the PCNA loading orientation deter-
mines the strand direction of MutL-α incision, target-
ing endonuclease action to the heteroduplex strand that 
contains a preexisting break [22, 23]. Incision in this 
manner introduces additional breaks, providing a 5′ nick 
that serves as a loading site for MutS-α-activated Exo1, 
which removes the mismatch. Upon completion of the 
mismatch excision process [24], DNA pol δ synthesizes 
DNA in the place of the excised sequence and DNA 
ligase I then joining any nicks in the DNA sequence [21]. 
While this human mismatch repair pathway may recog-
nize base analogs and damaged bases [25] our previous 
attempts to show in  vitro processing of a dI containing 
heteroduplexes by bacterial MutHLS mismatch repair 
pathway was insignificant [9, 11]. However the possibility 
of overlapping repair activities for dI process in human 
mismatch repair was not tested.
In this study a convenient and non-radioisotopic 
method was used to study dI repair in mammalian cells. 
Specifically, we took advantage of a functional assay that 
uses DNA substrates containing a dI residing in the rec-
ognition site or cleavage site of restriction enzymes. 
Substrates processed by human cell-free extracts can be 
scored by restriction enzyme cleavage to evaluate the 
repair of dI. We found that all four dI lesions of A-I, C-I, 
G-I and T-I can be processed by human extracts with 
different efficiencies. We also performed a comparative 
examination of repair requirements of different dI con-
taining substrates in vitro and the results indicated that 
there were overlapping activities of several repair path-
ways in processing of dI in DNA.
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Results
Deoxyinosine‑containing substrates are efficiently 
processed in Hela cell extracts
Previously, to evaluate EndoV repair system in E. coli, 
we constructed a set of dI-containing substrates A-I, G-I 
and T-I heteroduplexes [9, 11]. In these substrates, a dI 
resided in a disrupted restriction endonuclease recog-
nition or cleavage site (Fig.  1). We employed a restric-
tion endonuclease assay to score for the repair of dI. In 
the presence of dI lesion, heteroduplex DNA is refrac-
tory to restriction endonuclease cleavage. After in  vitro 
repair the specific restriction endonuclease recognition 
sequence was restored and repair level can be scored by 
the extent of restriction digestion [9, 11]. In this study, 
we added newly constructed C-I substrate (Fig. 1) to this 
assay platform and extended our study to determine the 
dI repair efficiency in human nuclear extracts.
We first tested G-I repair in nuclear extracts from a 
HeLa cell line. In a preliminary trial, reaction conditions 
for both E. coli dI repair [9, 11] and human MMR [26] 
were tested. To our surprise, the G-I substrate was only 
marginally repaired by human nuclear extracts in reac-
tion buffer for E. coli dI repair (Fig. 2a, 0 mM entry), but 
in human MMR reaction buffer, it was efficiently cor-
rected (Fig.  2a, 1  mM entry). The major difference in 
these two reaction buffers was human MMR buffer con-
tained 1 mM ATP while E. coli dI repair buffer contained 
no ATP. We therefore did an ATP titration experiment as 
shown in Fig.  2a. We found the presence of ATP could 
stimulate human dI repair. The highest level of correction 
occurred at a concentration of 2  mM ATP; higher ATP 
concentrations (>2  mM) caused extensive degradation 
of DNA and therefore inhibited the repair (Fig. 2a). We 
also performed a Mg2+ titration experiment as shown in 
Fig. 2b. The best repair level was at 2.5 mM, while higher 
Mg2+ concentrations were inhibitory.
A time course showing the amount of repaired prod-
ucts of a G-I heteroduplex when incubated with HeLa 
extracts is shown in Fig.  2c, d. Digestion of the unpro-
cessed heteroduplex G-I with AlwNI and XhoI, whose 
recognition sequence for XhoI is blocked by the pres-
ence of dI lesion, will yield a 7.2-kb linear fragment only 
(Fig.  2c, 0  min). However, digestion of DNA with both 
enzymes in which the XhoI recognition sequence has 
been restored by repair will yield 4.1- and 3.1-kb frag-
ments (Fig. 2c, 10–60 min). The repair efficiency can be 
determined by measurement of band intensity (Fig. 2d).
Although higher ATP concentrations (1.5–2  mM 
in Fig. 2a) and lower Mg2+ (2.5 mM in Fig. 1b) showed 
better dI repair activity, we decided using conventional 
human MMR reaction buffer containing 1  mM ATP 
and 5  mM  Mg2+ for standard dI repair assay in order 
to compare dI correction versus human MMR activities 
described in the subsequent section. As shown in Table 1, 
in human MMR buffer, A-I, C-I, G-I and T-I can be 
repaired with different efficiencies. The G-I heterodu-
plex was most efficiently corrected, and followed by T-I, 
A-I, and C-I substrates. The levels of repair were about 
25–60 % of our previous observed bacterial reactions [9, 
11].
Reaction requirements of dI repair in human extracts
In human dI repair, we adopted reaction conditions of 
in  vitro human mismatch repair for comparison. It is 
known that in  vitro human mismatch repair requires 
the addition of MgCl2, ATP and the four dNTPs [27]. In 
order to understand if all of these components are essen-
tial for dI repair, we systematically omitted the exogenous 
cofactors in separate reactions. As shown in Table  1, in 
the absence of Mg2+, the repair efficiency of all four dI 
substrates were reduced below the level of detection in 
HeLa extracts, which is consistent with that Mg2+ being 
an essential cofactor for most DNA repair enzymes [7, 15, 
27]. In the absence of exogenous dNTPs, the repair levels 
dropped to less than one-third of the standard reactions. 
The cell-free extracts prepared for this study may contain 
trace amount of dNTPs [26] and may contribute to these 
residual repair levels.
In the absence of exogenous ATP, the relative repair 
levels of each substrate showed variable degrees of 
decreasing activity when compared to standard ones 
(Table 1, HeLa entries). This is in contrast to our previous 
studies in E. coli where ATP was not required in bacterial 
dI repair [9, 11]. This effect might be caused by the fact 
that the human system employs multiple ATP-dependent 
repair proteins, for example, human uses ATP-dependent 
DNA ligase while E. coli uses NAD+-dependent ligase, 
respectively. The low level repair in the absence of exog-
enous ATP might be due to trace amounts of ATP in the 
cell-free extracts we prepared. Thus the increase in repair 
by addition of exogenous ATP might be due to insuf-
ficient ATP levels for some of the repair proteins. To 
clarify the role of ATP in the reaction, ATPγS, an ATP 
analog that is resistant to hydrolysis, was included in the 
reactions. In the G-I repair reaction, omitting ATP and 
addition of ATPγS showed a similar limiting of repair 
(Table 1). However, the repair efficiency of T-I substrates 
with HeLa extracts showed an extensive reduction when 
exogenous ATP was replaced by ATPγS in the repair 
reactions, with the repair levels in ATPγS reactions being 
even lower than the reactions omitting ATP. Therefore, 
the presence of an ATP cofactor and its hydrolysis were 
likely both essential for human T-I lesion repair. To deter-
mine if the ATP dependence was nucleotide triphosphate 
specific, we also tested the effects of exogenous GTP 
addition from 0.5 to 2  mM to G-I repair reactions; no 
Page 4 of 10Lee et al. Cell Biosci  (2015) 5:52 
b V 5'-CTAGGGTCTCCGGACCATAAGGTGGCACTAGA... f1PMA
C 3'-    CCAGAGGCCTGGIATTCCACCGTGATC
V 5'-CTAGTCCATACCATGGTGTGTATGGACTAGA.... M13WX1 





V 5'-CTAGTCACCACTCTAGAGGTGG............. M13X22 





















 V 5'-AGCTAGCAGCAGCAGCCTCGAGAGCTT........ M13LR1
 C 3'-    TCGTCGTCGTCGGAGITCTCGA    
PflMI
        XhoI
 V 5'-AGCTAGCAGCAGCAGCCTCGAAAGCTT........ M13LR3
 C 3'-    TCGTCGTCGTCGGAGCTTTCIA    








Fig. 1 Map of M13mp18 and f1PM based heteroduplex substrates. a The map of bacteriophage M13mp18 replicative form (RF) DNA shows restric‑
tion enzyme sites relevant to this study with derivatives M13LR1 and M13LR3 containing 22‑bp insertions at the unique HindIII restriction site, and 
phage M13WX1 and M13X22 containing 26‑bp and 22‑bp insertions at XbaI site respectively. b The map of bacteriophage f1PM RF DNA with its 
derivative f1PMA with a 27‑bp insertion at XbaI. ‘V’, phage viral strand. ‘C’, phage complementary strand. Underlines beneath each viral strand are the 
original insertion sequences. The C‑strand from parental phage RF DNA was paired with viral strand of its insertion derivative to produce gapped 
duplex DNA, and the gap was sealed with dI or deoxyuridine containing synthetic oligodeoxyribonucleotide. A‑I, C‑I, G‑I, T‑I, and G‑U are the result‑
ing substrates and DNA sequence shown on each C‑strand of the the synthetic linker used. In the presence of dI, the substrates were refractory 
to the restriction endonuclease scoring. After the repair, DNA products become sensitive to restriction endonuclease cleavage. The recognition 
sequence of corresponding restriction endonuclease markers for repair products are shown in bold on V‑strands
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obvious change of repair levels with GTP addition was 
observed compared to conditions without exogenous 
ATP (data not shown).
Both aphidicolin‑ and lithocholic acid‑sensitive DNA 
polymerases were involved in correcting dI in mammalian 
cells
Several classes of DNA polymerases have been identified 
in different DNA repair pathways. For example, pol δ is 
involved in MMR [28, 29], nucleotide excision repair [30, 
31] and long-patched BER [32] pathways. In classic mam-
malian short-patched BER pathway, pol β is responsible 
for the repair DNA synthesis [33, 34]. In order to evalu-
ate the involvement of DNA polymerases in repairing dI, 
an inhibitor targeting pol α, δ and ε was added into the 
repair reactions. Aphidicolin has been found to block the 
repair DNA synthesis in MMR system [26, 27]. The repair 
of C-I was not sensitive to aphidicolin inhibition (Fig. 3a). 
The repair of G-I, T-I, and A-I were significantly reduced 
by addition of aphidicolin at the concentration of 30 μM 
in HeLa extract-containing repair reactions (Fig.  3a). 
However, as the concentration of aphidicolin increased 
to above 90 μM, at which pol δ dependent MMR should 
be abolished [26, 27], relatively high levels of residual dI 
repair remained. This observation suggested both aphid-
icolin-sensitive and aphidicolin-resistant DNA polymer-
ases participating dI lesions repair, in addition to possible 
overlapping repair mechanisms for dI repair in human 
cells.
Deoxyinosine was thought to be repaired by base exci-
sion repair in mammalian cells [35, 36]. In classic mam-
malian short-patched BER pathway, pol β is responsible 
for the repair DNA synthesis. A bile acid derivative litho-
cholic acid (LCA) can bind to pol β and disrupts its AP 
lyase ability to block the DNA replication functions, with 
the Ki value of 10 μM [37]. We therefore introduced this 
DNA polymerase β inhibitor into dI repair reactions in 
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Fig. 2 ATP, Mg++ titrations and time course of G‑I repair in human 
nuclear extracts. Each reaction contained 90 μg HeLa extracts and 
21 fmol G‑I substrate. a Repair reactions with HeLa extracts were 
determined as described in Methods except that where indicated 
ATP was added. b Repair reaction with HeLa extracts were performed 
as described in Methods except where indicated Mg2+ was added. 
c Reactions were performed under standard conditions and scaled; 
10‑μl samples were removed as indicated. DNA products were 
digested with AlwNI and XhoI and then subjected to agarose gel 
electrophoresis to score for the repair of dI lesion. The bar pointing to 
the 7.2‑kb fragment represents unrepaired substrate linearized with 
AlwNI; size marker (M) of 4.1 and 3.1‑kb fragments are indicative of 
repaired products that were generated by treatment of M13LR1 with 
AlwNI and XhoI. d Quantitative analysis of the time course reaction, 
the error bars represent S.D. from three determinations
Table 1 Repair requirement of dI-containing heteroduplex in extracts from MMR-proficient and MMR-deficient mamma-
lian cells
Repair efficiency was determined as described in “Methods”. Twenty-one fmol of dI-containing DNA was incubated with 90 μg of HeLaS3 or HCT116 cell-free extracts 
at 37 °C for 30 min. Repair level lower than 0.3 fmol was regarded as background (–). Each data corresponds to the average and standard deviation from at least three 
independent measurements. Statistical analysis: * p < 0.05, ** p < 0.001, *** p < 0.001 versus Standard reaction (Student’s t-test)
Reaction condition Repair levels (fmol)
HeLaS3 HCT116
G‑I T‑I A‑I C‑I G‑I T‑I A‑I C‑I
Standard 7.6 ± 1.3 3.8 ± 0.8 3.0 ± 0.6 2.4 ± 0.2 3.2 ± 0.5 2.3 ± 0.6 1.1 ± 0.3 0.9 ± 0.09
Mg2+ (‑) –*** –*** –*** –*** –*** –*** –*** –***
dNTP (‑) 1.7 ± 0.1*** 1.2 ± 0.2*** 0.6 ± 0.1*** 1.0 ± 0.1** 1.2 ± 0.4** 1.1 ± 0.8 –*** 0.7 ± 0.09
ATP (‑) 4.7 ± 0.2*** 2.8 ± 1.0 2.0 ± 0.3** 1.1 ± 0.1** 2.2 ± 0.6 1.5 ± 0.2** 0.8 ± 0.02 0.7 ± 0.07*
ATPγS 4.3 ± 0.01*** 1.0 ± 0.4*** 0.7 ± 0.1*** 1.1 ± 0.1** 2.9 ± 0.6* 0.3 ± 0.4*** 1.0 ± 0.2 0.8 ± 0.02
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of dI heteroduplex DNA were impaired with lithocholic 
acid treatments with a dose dependency. This observa-
tion suggested that pol β and possibly short-patched BER 
are involved in repairing dI lesions in mammalian cells. 
At the concentration of LCA at 50 μM, at which pol β 
activity should be near background level [37], relatively 
high levels of residual dI repair remained (more than 
50 % of activity relative to standard reactions). Since pol 
δ and ε were not affected by 50 μM LCA [37], it’s possi-
ble these LCA-resistant DNA polymerases participate in 
repair of dI lesions.
A hereditary non‑polyposis colorectal cancer cell line 
showed lower repair activity toward certain dI lesions
It is known that mismatch repair activity not only can 
repair mismatches, but also may recognize base ana-
logs as well. The A-I, C-I, G-I and T-I substrates we pre-
pared share a great deal of similarity to mismatches. It is 
also known that ATP is required in the mismatch repair 
pathway and our exogenous ATP and ATPγS experimen-
tal data were strongly suggested possible involvement of 
mismatch repair in human dI lesion repair. In order to 
clarify this issue, we employed extracts from a mismatch 
repair deficient HCT116 cells in our dI repair assay.
To ensure the quality of both HeLa and HCT116 
extracts were comparable, a G-U substrate (Fig.  1) was 
prepared to evaluate their BER activity. Using the repair 
assay conditions described above, both cell extracts could 
actively repair G-U substrate. In a reaction of 21 fmol 
G-U substrate, repair levels from HeLa was 17.9  ±  0.2 
fmol and from HCT116 was 17.4 ± 0.3 respectively.
However, we found the repair levels of HCT116 
decreased about 60  % in G-I, 35  % in T-I, 66  % in A-I, 
and 38  % in C-I substrates when compared to repair 
levels derived from HeLa cells (Table 1). We also deter-
mined the repair requirements for HCT116 extracts 
(Table 1). In the absence of exogenous dNTPs, the repair 
levels dropped to near background for A-I to less than 
half of the standard reactions for G-I and T-I (Table 1). 
In the absence of exogenous ATP, the repair levels of 
HCT116 for each substrate also showed variable degrees 
of decreasing repair when compared to standard ones 
(Table  1, HCT116 entries). It is very interesting to note 
that the repair efficiency of T-I showed an extensive 
reduction in both HeLa and HCT116 extracts when 
exogenous ATP was replaced by ATPγS in the repair 
reactions. This implies that the T-I specific repair mecha-
nism exists in human cell relies on ATP hydrolysis.
Since HCT116 lacks functional MutL-α for mismatch 
repair, the observation described above prompted us to 
test the involvement of MutL-α in human dI repair. As 
shown in Fig.  4, supplemented purified human MutL-α 
to MMR proficient HeLa extracts showed no signifi-
cant change in 5′G-T repair levels (Fig. 4, HeLa entries). 
However, supplementing of MutL-α to HCT116 extracts 
was able to restore its MMR activity for both 3′-G-T and 
5′-G-T heteroduplexes. Addition of MutL-α to HCT116 
extracts also increased the G-I repair level comparably 
to that of HeLa extract containing reactions (Fig.  4 and 
G-I entry in Table 1). However, the processing of A-I, C-I 
and T-I showed no significant change in the presence or 
absence of MutL-α (Fig.  4). This observation suggested 
human MMR enzymes can recognize and process G-I 
but not A-I, C-I and T-I lesions.
Discussion
Deamination of purine bases can occur spontaneously. 
The conversion rate of adenine to hypoxanthine in DNA 
under physiological condition is about 2 % of the rate of 
the conversion of cytosine to uracil [2], which in turn is 
about 2–5 times per human cell per day [38]. The result-
ing I-T mismatch in DNA is potentially mutagenic since 








































Fig. 3 Inhibitory effects of aphidicolin and lithocholic acid on dI 
correction in mammalian cell‑free extracts. Heteroduplexes G‑I, 
T‑I, C‑I and A‑I (21 fmol) were incubated with 90 μg HeLa extracts 
containing indicated DNA polymerases inhibitors for 30 min at 37 °C. 
Reactions were analyzed by gel electrophoresis after restriction endo‑
nuclease digestion with AlwNI and the scoring enzymes. a Addition 
of aphidicolin. b Addition of Lithocolic acid. Each data corresponds 
to the average and standard deviation (error bars) from at least three 
independent reactions
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a dI in the DNA template prefers to pair with dCTP 
during replication, yielding A:T to G:C transition muta-
tions at sites of adenine deamination [5]. Therefore dI in 
DNA should be removed by living organisms to maintain 
genome integrity.
Previously we developed an in  vitro assay for bacte-
rial repair and found that different dI-containing sub-
strates were predominately repaired by the EndoV repair 
pathway [11]. In this study, we took advantage of our 
previously described bacterial dI in vitro repair assay to 
determine repair capabilities in human cell-free extracts 
for all four dI-containing A-I, C-I, G-I and T-I substrates. 
Similar to E. coli, we found that human cell extracts can 
also efficiently process dI lesions. However, some sig-
nificant differences do exist between human and bac-
terial reactions. In the reactions withholding specific 
exogenous cofactors, we found that high concentrations 
of exogenous ATP was required for the human reac-
tion (Table 1) but not in the bacterial reaction [11], This 
observation might be attributed to some of mammalian 
DNA processing proteins requirement for ATP for their 
enzymatic reactions. Mammalian DNA ligases, PCNA 
loader (RFC), MutS-α, MutL-α are among the likely ATP 
utilizing candidates involved in the reaction.
As to substrates specificity, under similar reaction con-
ditions, we found G-I was the best substrate for human 
cell extracts followed by T-I, A-I and C-I. This hierarchy 
of repair specificity in human cells is different from what 
we previously reported in the bacterial system i.e. T-I is 
a better substrate than A-I and G-I [11]. In E. coli, both 
in vivo and in vitro studies suggested that EndoV pathway 
is the major system for processing dI lesions. All the 
mutagenic dI-containing DNA of A-I, G-I and T-I were 
repaired with similar biochemical process in  vitro [11] 
and with the same genetic requirements for in vivo cor-
rection [8]. However, correction of dI in human extracts 
appears to be more complex. We suspect there are multi-
ple overlapping dI repair activities judging from different 
repair responses for G-I, T-I, C-I and A-I with specific 
inhibitors.
It is not uncommon for repair proteins or pathways 
to demonstrate overlapping specificity toward the same 
DNA errors or lesions. For example, to deal with cytosine 
deamination, mammalian cells utilize four nuclear ura-
cil DNA glycosylases (UDGs), namely, UNG2, SMUG1, 
TDG and MBD4 [39]. Likewise, BER was thought to 
be the major pathway for dI repair in mammalian cells. 
According to the model, hypoxanthine (Hx) would 
be bound and excised relatively efficiently by human 
N-methylpurine-DNA glycosylase (MPG, also known as 
AAG, ANPG, APNG, and MDG) [6]. The human MPG 
has a broad substrate specificity, excising a structur-
ally diverse group of modified purines from DNA [40]. 
Single-turnover kinetics of excision of Hx paired with T 
showed that excision of Hx was very fast relative to any 
other damaged purines. However, the opposing pyrimi-
dine base had a significant effect on the kinetics of exci-
sion and DNA binding affinity of Hx; replacing a T with 
a U opposite Hx dramatically reduced the excision rate 
[35]. In mammalian cells, pol β is responsible for the 
dominant 1-nucleotide replacement or so-called short-
patch BER pathway. In long-patch BER pathway, DNA 
A-I G-I T-I 5’G-T3’G-T
0  50 100 0  50 100 0  50 100 0  50 100 0  50 100

















0  50 1000  50 100
HeLa
Fig. 4 MuL‑α complementation assay for Hct116 extracts. Heteroduplex A‑I, C‑I, G‑I, T‑I, 3′G‑T and 5′G‑T (21 fmol) as indicated were incubated with 
90 μg Hct116 extracts in the absence (white bar) or presence of 50 ng (gray bar) or 100 ng (black bar) of human MutL‑α recombinant protein. Repair 
of 5′G‑T with HeLa was included as a control. Each data-bar corresponds to the average and standard deviation (error bars) from at least three inde‑
pendent reactions. **p < 0.01 versus addition of exogenous MutL‑α (Student’s t test)
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Pol δ or ε, FEN1, PCNA and DNA ligase I are required for 
gap filling and deoxyribosephosphate removal.
An initial effort toward identifying the requirements in 
our human dI repair assay was to use DNA polymerase 
inhibitors. Using lithocholic acid or aphidicolin treat-
ments, the repair of G-I, C-I, T-I, and A-I were partially 
inhibited in reactions containing HeLa extracts (Fig.  3). 
This observation implies the possible role for both a 
lithocholic acid sensitive polymerase (i.e. β) and aphidi-
colin sensitive polymerases (i.e. α, δ or ε) in dI repair. 
Different repair specificities toward A-I, C-I, G-I, and 
T-I substrates and involvement of both lithocholic acid 
sensitive and aphidicolin sensitive DNA polymerases are 
an indication of possible involvement of both short- and 
long- patch BER pathway. Our observation is consistent 
with a previous report that repair of a hypoxanthine resi-
due initiated by the MPG utilizes both short- and long-
patch repair synthesis [7].
The A-I, C-I, G-I and T-I mispairs share some similar 
features to base–base mismatches and cause protrusion 
of the DNA duplex [41]. However, in E. coli, both in vivo 
and in vitro studies showed the mismatch repair pathway 
plays little, if any role in processing dI lesions [8, 9, 11]. 
Using extracts from an MMR-deficient HNPCC cell line 
with a complementation assay demonstrated that G-I 
substrate could be partially processed by MMR pathway 
(Fig. 4). A notable finding from this study is that we found 
extracts of HCT116 showed lower dI processing capabil-
ity compared to HeLa cell extracts. HCT116 is defective 
in mismatch repair due to a lack of human MutL-α activ-
ity indicating a possible role of the mismatch repair pro-
tein MutL-α in processing dI lesions. However, we found 
the deficiency was not completely due to mismatch repair 
since addition of recombinant MutL-α, which can restore 
HCT116’s MMR activity, failed to significantly increase 
the repair levels of T-I, C-I and A-I substrates, while sig-
nificantly improving G-I repair (more than 50 % increase 
as shown in Fig.  4). A single-strand break is required 
to initiate repair and to provide strand specificity for 
human MMR [26]. Structurally similar to mismatches, 
covalently-closed-circular G-I substrate may be detected 
by MutS-α which subsequently stimulates MutL-α nick-
ing activity to initiate the repair [22, 23]. Alternatively, 
an incision created by an EndoV-like activity [42] might 
be sufficient to direct the repair. The interaction between 
EndoV and MMR enzymes for G-I processing remains to 
be determined.
EndoV from E. coli has been shown to have similar 
activity on oligodeoxynucleotides containing T-I, C-I, G-I 
or A-I pairs [13]. Recently, the human EndoV homologue 
was identified and characterized [16]. The mammalian 
EndoV showed lower endonucleolytic activity than E. coli 
homologues towards dI lesions [15, 16]. The activity of 
mammalian EndoV was most active on G-I followed by 
T-I>A-I>C-I [16]. In combination with the overlapping 
repair of G-I by MMR, this might explain our findings 
that G-I was most efficiently processed followed by T-I, 
A-I, and C-I (Table 1). Further study is required to clarify 
this issue.
Variations in DNA repair activities are connected to 
both individual and population disease susceptibilities 
[43, 44], Several DNA repair defects have been linked to 
cancers [43, 44]. Oxidatively damaged DNA and its repair 
are also positively correlated in colon carcinogenesis [45]. 
Increased risk of lung cancer is associated with a func-
tionally impaired polymorphic variant of the human 
DNA glycosylase NEIL2 [46]. Thus, studying DNA repair 
activities in human cells is an important issue. A very 
interesting finding from this study is that we found that 
HNPCC cell line HCT116 showed lowered dI processing 
capability in part because of its MMR deficiency (for part 
of G-I repair) and possibly other mechanism(s) for T-I, 
C-I and A-I repair. Production of dI can be enhanced by 
exposure of DNA with nitrite ion. Nitrites are commonly 
used in the food production industry for curing meat. 
It’s likely that the digestive tract e.g. the colon would be 
exposed and affected by nitrite when consuming pre-
served meat items. Patients of putative HNPCC families 
might be more susceptible to this mutagenic effect. The 
interrelationship of a MMR deficiency and other dI repair 
activities in HNPCC tumors needs to be determined. The 
dI repair assay described in this study provides a good 
platform for further investigation.
Conclusions
In this study a plasmid-based convenient and non-radi-
oisotopic method was introduced to study dI repair in 
human cells. All four possible dI lesions of A-I, C-I, G-I 
and T-I processed by human cell-free extracts could be 
scored by restriction enzyme cleavage to evaluate the 
repair. In addition, repair derived from a MMR deficient 
cancer cell line was less efficient in dI repair that was 
partially attributed to lack of MutL-α. The repair assay 
described in this study provides a good platform for fur-
ther investigation of human repair pathways involved in 
dI processing and their biological significance in muta-
tion and cancer prevention.
Methods
Materials
Bacteriophage M13LR1 and M13LR3 were derivatives 
of M13mp18 with a 22-base pair (bp) insertion at Hin-
dIII site [47]. M13WX1 and M13X22 were derivatives of 
M13mp18 with 26 and 22-bp insertion at XbaI site, and 
phage f1PM-A was a derivative of f1PM with a 27-bp 
insertion at XbaI site [11] (Fig. 1). E. coli DNA ligase, T4 
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polynucleotide kinase, HindIII-HFTM and other restric-
tion endonucleases were obtained from New England 
Biolabs. RecBCD nuclease was purchased from EPICEN-
TRE Biotechnologies. Aphidicolin and lithocolic acid 
were purchased from Sigma and dissolved in DMSO. 
Recombinant human MutL-α was kindly provided by Dr. 
Paul Modrich (Duke University).
Cell culture and preparation of human cell‑free nuclear 
extracts
The human cell line HeLa S3 were grown in 10  % FBS 
supplemented DMEM/F12 medium (Sigma), and Hct116, 
a mismatch repair deficient colorectal carcinoma cell 
line were grown in 10 % FBS supplemented RPMI 1640 
medium (Biological Industry) at 37  °C under a 5 % CO2 
atmosphere.
Human cell-free nuclear extracts was prepared as 
described [27]. In brief, human cell lines were cultured to 
a total cell number about 2 × 109 cells. Cells were washed 
twice with a buffer of 20 mM HEPES (pH7.5), 5 mM KCl, 
0.2 M sucrose, 0.5 mM MgCl2, 0.1 % PMSF, and 0.5 mM 
dithiothreitol, and then incubated in a hypotonic solution 
of 20  mM HEPES (pH7.5), 5  mM KCl, 0.5  mM MgCl2, 
0.1 % PMSF, and 0.5 mM dithiothreitol. Cells were lysed 
with a dounce homogenizer, nuclei were collected by 
centrifugation. Nuclear protein were extracted in 50 mM 
HEPES (pH7.5), 10  % sucrose, 0.1  % PMSF, 155  mM 
NaCl, and 0.5 mM dithiothreitol, and then concentrated 
by ammonium sulfate precipitation (0.42 g/ml). The pel-
let was dialyzed against 25 mM HEPES (pH7.5), 50 mM 
KCl, 0.2 % PMSF, and 1 mM dithiothreitol until the con-
ductivity achieved a value equivalent to that of 0.1–0.2 M 
KCl. The soluble fraction was frozen in small aliquots in 
liquid nitrogen and stored at −80 °C.
Batch to batch variation of cell-free nuclear extracts for 
repair activity was quite high (up to 30 % differences for 
standard reaction). Higher S.D. in some data reflected 
using average of equal number measurements from dif-
ferent batch of extracts.
Deoxyinosine‑containing heteroduplex DNA substrates
Preparation of heteroduplex DNA substrates was car-
ried out by annealing a 5′-phosphorylated dI-contain-
ing oligonucleotides (Fig.  1) to a gap-duplex DNA and 
then sealed by T4 DNA ligase as described [11]. All the 
covalently-closed-circular dI containing substrates were 
purified by CsCl-Ethidium bromide density gradient cen-
trifugation. The key feature of prepared A-I, C-I, G-I and 
T-I substrates were summarized in Fig. 1. All of the dI-
containing substrates were confirmed to be refractory to 
respective diagnosis restriction endonuclease cleavage 
prior the repair reaction.
Repair assays using cell‑free extracts
The deoxyinosine repair assay with human extracts was 
similar to a human mismatch repair assay as described 
[26]. Briefly, 21 fmol of DNA substrate was incubated 
with 90 to 105 μg of human nuclear extracts in a 20-μl 
reaction containing 20  mM Tris–HCl (pH 7.6), 50  μg/
ml bovine serum albumin, 5 mM MgCl2, 1 mM ATP, and 
0.1  mM each of the four dNTPs. Reactions were incu-
bated for 30 min at 37 °C and quenched by adding 40 μl 
of 40  mM EDTA (pH8.0). DNA was isolated by phe-
nol extraction and ethanol precipitation, and was then 
digested with AlwNI and the indicated scoring restric-
tion enzymes. The resulting products were separated by 
agarose gel electrophoresis, and detected by ethidium 
bromide staining. The gel-images were captured by a gel 
documentation CCD camera (UVP Ltd.) using View-
finder 3.0, and band intensities were then measured by 
NIH Image J 1.45 s software.
A DNA mismatch repair assay using nicked 5′-GT and 
3′-GT heteroduplex was as described [48]. In the MutL-α 
complementation assay, purified MuL-α protein was sup-
plemented to the HCT116 nuclear extracts and the repair 
assay was as described above.
A G-U substrate (Fig. 1) was prepared to evaluate BER 
activity of Hela and Hct116 extracts. The G-U repair 
assay is similar to dI assay described above.
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